Rational use of cancer chemotherapeutic drugs

By | April 29, 2012

The rational use of cancer chemotherapeutic drugs, many people, including some of the medical staff believed that cancer chemotherapy is based on experience, to choose some form of chemotherapy drugs chemotherapy, and then give the patient a transfusion even if the completion of chemotherapy. In fact, this is a serious misunderstanding. Cancer chemotherapy is not only the medical oncologists, a clinical and experimental oncology oncology theory and cancer patients the combination of specific clinical conditions and serious scientific research; also a requirement of Clinical Oncology physicians to use their wealth of internal medicine experience and extensive knowledge of multi-disciplinary research combining artistic practice. Years ago, the International Union Against Cancer experts pointed out, cancer and 1 / 3 can be prevented; 1 / 3 is curable; 1 / 3 through the treatment can improve quality of life and prolong survival.
As a cancer physician, in considering how to plan for cancer chemotherapy patients develop when:
Should first consider whether the patient has chemotherapy indications;
Secondly, we should consider whether the patient successfully completed scheduled chemotherapy (including the patient's compliance); Finally, it should be considered for Pharmacoeconomics and benefit / cost ratio.
In addition, physicians should also understand the malignant tumors of other treatments such as surgery, radiotherapy, interventional therapy and traditional Chinese medicine treatment methods and the implementation status of the patient; explicitly include a variety of cancer chemotherapy, including the best treatment timing and use of patient prognosis.
For example, a patient after a diagnosis of pathology or cytology of gastric cancer tissue, the patient required chemotherapy. The face of such patients, physicians should be aware of tumor surgery is the preferred treatment of gastric cancer, the only treatment to cure. Should first determine whether the patient has surgery indications, if not surgery, the possibility of using chemotherapy, radiotherapy or other treatments, surgical removal of the patient the opportunity to create (such as preoperative chemotherapy, etc.); if the patient just had radical surgery, the patient's surgical records, pathology reports, the results of tumor markers, whether postoperative adjuvant chemotherapy should be prompt, and when to start adjuvant chemotherapy; if the patient is late recurrence or metastasis in patients with or without surgical emergency now in need of emergency treatment, the need for palliative surgery or palliative radiotherapy, the need for intervention (such as arterial chemotherapy, biological stent placement, etc.), intra-abdominal chemotherapy, chemotherapy and other means; if the patient has never had chemotherapy, the patient's physical condition and economic capacity of what is acceptable and dose intensity of chemotherapy, the patient should also be based on the specific situation and current progress in cancer chemotherapy, the patient estimated the likelihood of chemotherapy, the patient is expected to occur in the chemotherapy side effects which , what with the chemotherapy of these adverse reactions related to chemotherapy, which has nothing to do with, how each dealt with separately; if chemotherapy is not valid, but also what kind of rescue treatment, how much of these treatments to give patients the benefits; and so forth.
The rational use of cancer chemotherapeutic drugs, a qualified physician even if the tumor clinical experience is limited, and subject to their own efforts, and medical oncologists to ask about a higher level after the above questions should give a satisfactory answer as far as possible.

Leave a Reply

Your email address will not be published. Required fields are marked *